NextCure Inc. (NASDAQ: NXTC) and Simcere Zaiming Pharmaceutical Co. will present Phase 1 data for SIM0505 at the American Society ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE